G. Gaube

Case Report: Cerebral Nocardiosis Caused by Nocardia cyriacigeorgica Detected by Metagenomics in an Apparently Immunocompetent Patient

J. Pawlotsky, P. Woerther, C. Angebault, 2022, Frontiers in Immunology.

Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study

E. Audureau, D. Boutboul, P. Grimbert, 2019, Journal of clinical medicine.

Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study.

S. Siméon, R. Lepeule, P. Lesprit, 2021, International journal of antimicrobial agents.

Characterization of HIV-1 diversity in various compartments at the time of primary infection by ultradeep sequencing

C. Delaugerre, A. Amara, J. Molina, 2020, Scientific Reports.

Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2

F. Carrat, R. Liblau, G. Martin-Blondel, 2022, Journal of Infection.

Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)

F. Carrat, R. Liblau, G. Martin-Blondel, 2022, Journal of Infection.

Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018.

C. Charpentier, R. Tubiana, C. Katlama, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Clinical Spectrum and Outcome of Uveomeningitis: A Comprehensive Analysis of 110 Cases

L. Mouthon, J. Hadjadj, A. Brézin, 2021, Ocular immunology and inflammation.

Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis.

A. Alanio, A. Guéguen, A. Zagdanski, 2016, Medecine et maladies infectieuses.

Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir

F. Carrat, R. Liblau, G. Martin-Blondel, 2022, Clinical Microbiology and Infection.

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies

J. Izopet, N. Kamar, G. Martin-Blondel, 2022, Open forum infectious diseases.